glp 1 alzheimer's 🧠 Researchers are exploring whether GLP-1 medications used for #diabetes and weight loss could treat #Alzheimers and addiction, but public concerns persist about long-term safety. 🔗 Read the full article at beingpatient.com # GLP-1 Receptor Agonists in Neurodegeneration:

A total of 448 patients received at least one dose of protocol-specified therapy

Patients should seek urgent medical attention if they develop severe, persistent abdominal pain

Like all medications there is a chance of side effects

Serum levels of 25-hydroxyvitamin D3 negatively correlate with endometriosis (124)

Protocol 4: degenerative disc disease and facet arthritis (advanced) Goal: Slow degenerative processes and support tissue quality in chronic spinal degeneration Peptides: BPC-157 : 500mcg twice daily ongoing GHK-Cu : 2mg daily for tissue regeneration KPV : 300mcg daily for anti-inflammatory effects Optional : TB-500 2mg weekly for systemic support Duration: Extended protocols, potentially cycling on and off Why this works: Degenerative conditions require ongoing support rather than acute treatment

& Kobilka, B